Cargando…

Reply to “Antiviral and anti-inflammatory properties of ivermectinand its potential use in Covid-19”()

Detalles Bibliográficos
Autores principales: Accinelli(), Roberto Alfonso, Portmann-Baracco, Arianna, Bryce-Alberti, Mayte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SEPAR. Published by Elsevier España, S.L.U. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647406/
https://www.ncbi.nlm.nih.gov/pubmed/33994642
http://dx.doi.org/10.1016/j.arbr.2020.11.002
_version_ 1783606904908414976
author Accinelli(), Roberto Alfonso
Portmann-Baracco, Arianna
Bryce-Alberti, Mayte
author_facet Accinelli(), Roberto Alfonso
Portmann-Baracco, Arianna
Bryce-Alberti, Mayte
author_sort Accinelli(), Roberto Alfonso
collection PubMed
description
format Online
Article
Text
id pubmed-7647406
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SEPAR. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-76474062020-11-09 Reply to “Antiviral and anti-inflammatory properties of ivermectinand its potential use in Covid-19”() Accinelli(), Roberto Alfonso Portmann-Baracco, Arianna Bryce-Alberti, Mayte Arch Bronconeumol Letter to the Editor SEPAR. Published by Elsevier España, S.L.U. 2020-12 2020-11-06 /pmc/articles/PMC7647406/ /pubmed/33994642 http://dx.doi.org/10.1016/j.arbr.2020.11.002 Text en © 2020 SEPAR. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Accinelli(), Roberto Alfonso
Portmann-Baracco, Arianna
Bryce-Alberti, Mayte
Reply to “Antiviral and anti-inflammatory properties of ivermectinand its potential use in Covid-19”()
title Reply to “Antiviral and anti-inflammatory properties of ivermectinand its potential use in Covid-19”()
title_full Reply to “Antiviral and anti-inflammatory properties of ivermectinand its potential use in Covid-19”()
title_fullStr Reply to “Antiviral and anti-inflammatory properties of ivermectinand its potential use in Covid-19”()
title_full_unstemmed Reply to “Antiviral and anti-inflammatory properties of ivermectinand its potential use in Covid-19”()
title_short Reply to “Antiviral and anti-inflammatory properties of ivermectinand its potential use in Covid-19”()
title_sort reply to “antiviral and anti-inflammatory properties of ivermectinand its potential use in covid-19”()
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647406/
https://www.ncbi.nlm.nih.gov/pubmed/33994642
http://dx.doi.org/10.1016/j.arbr.2020.11.002
work_keys_str_mv AT accinellirobertoalfonso replytoantiviralandantiinflammatorypropertiesofivermectinanditspotentialuseincovid19
AT portmannbaraccoarianna replytoantiviralandantiinflammatorypropertiesofivermectinanditspotentialuseincovid19
AT brycealbertimayte replytoantiviralandantiinflammatorypropertiesofivermectinanditspotentialuseincovid19